Related Experiment Videos
[Sentinel lymph node dissection in prostate cancer. Experience after more than 800 interventions].
1Urologische Klinik, Klinikum, Stenglinstrasse 2, 86156, Augsburg. dorothea.weckermann@uro.augsburg-med.de
Der Urologe. Ausg. A
|April 6, 2006
Summary
For prostate cancer patients, even those with low-risk disease, lymph node dissection is recommended. Sentinel lymph node dissection can identify metastases outside standard areas, potentially improving patient prognosis.
Area of Science:
- Urology
- Oncology
- Surgical Pathology
Context:
- Current prostate cancer treatment guidelines lack consensus on lymph node dissection extent.
- Nomograms are often used to guide decisions, leading to omitted dissection in low-risk cases.
- Existing research suggests lymph node metastases can occur in low-risk prostate cancer and may be located outside standard dissection regions.
Purpose:
- To investigate the prevalence and location of lymph node metastases in a large cohort of prostate cancer patients.
- To evaluate the efficacy of sentinel lymph node dissection (SLND) in identifying these metastases.
- To determine the clinical utility of lymph node dissection in all prostate cancer patients.
Summary:
- Analysis of over 800 men revealed lymph node metastases more frequently than predicted by Partin tables.
- Sentinel lymph node dissection identified metastases in regions beyond standard and extended lymphadenectomy.
- Preoperative diagnostics are insufficient to accurately identify patients with positive lymph nodes.
Impact:
- Findings challenge current risk stratification and nomogram use for prostate cancer lymph node management.
- Performing lymph node dissection in all patients may be beneficial due to frequent, unexpected metastases.
- Sentinel and extended lymph node dissection in men with positive nodes could lead to improved prognoses.